Abstract | BACKGROUND & AIMS: METHODS: CD4+ mesenteric lymph node cells from SAMP-1/Yit donor mice were adoptively transferred into major histocompatibility complex-matched severe combined immunodeficiency disease mice. Six weeks later, these mice were left untreated or treated for 3 days with monoclonal antibodies (mAbs) to ICAM-1, VCAM-1, or both, and alpha(4), or both ICAM-1 and alpha(4), dexamethasone, or nonblocking isotype control antibodies. On day 4 after treatment, tissues were investigated for expression of ICAM-1, VCAM-1, and for severity of inflammation using a semiquantitative inflammatory score. Dexamethasone treatment resolved all measures of intestinal inflammation. RESULTS: CONCLUSIONS: These findings suggest that blocking ICAM-1 and VCAM-1 may have therapeutic benefit for the acute inflammatory component of Crohn's disease.
|
Authors | R C Burns, J Rivera-Nieves, C A Moskaluk, S Matsumoto, F Cominelli, K Ley |
Journal | Gastroenterology
(Gastroenterology)
Vol. 121
Issue 6
Pg. 1428-36
(Dec 2001)
ISSN: 0016-5085 [Print] United States |
PMID | 11729122
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antibodies, Monoclonal
- Antigens, CD
- Cdkn1a protein, mouse
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
- Vascular Cell Adhesion Molecule-1
- Intercellular Adhesion Molecule-1
- Integrin alpha4
|
Topics |
- Adoptive Transfer
- Animals
- Antibodies, Monoclonal
(immunology)
- Antigens, CD
(immunology)
- Colitis
(immunology, metabolism, pathology)
- Colon
(metabolism, pathology)
- Crohn Disease
(immunology, metabolism, pathology)
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
(immunology)
- Integrin alpha4
- Intercellular Adhesion Molecule-1
(immunology, metabolism)
- Mice
- Mice, Inbred Strains
- Mice, SCID
- Microvilli
(pathology)
- Vascular Cell Adhesion Molecule-1
(immunology, metabolism)
|